Novel Drug For Schizophrenia To Hit The Market Following FDA Approval
Intra-Cellular Therapies Inc. was given approval by the FDA to commercially launch Caplyta, a new drug to treat schizophrenia.
Read Original Article: Novel Drug For Schizophrenia To Hit The Market Following FDA Approval »
